APA (7th ed.) Citation

Jayavaradhan, R., Pillis, D. M., Goodman, M., Zhang, F., Zhang, Y., Andreassen, P. R., & Malik, P. (2019). CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites. Nature Portfolio.

Chicago Style (17th ed.) Citation

Jayavaradhan, Rajeswari, Devin M. Pillis, Michael Goodman, Fan Zhang, Yue Zhang, Paul R. Andreassen, and Punam Malik. CRISPR-Cas9 Fusion to Dominant-negative 53BP1 Enhances HDR and Inhibits NHEJ Specifically at Cas9 Target Sites. Nature Portfolio, 2019.

MLA (8th ed.) Citation

Jayavaradhan, Rajeswari, et al. CRISPR-Cas9 Fusion to Dominant-negative 53BP1 Enhances HDR and Inhibits NHEJ Specifically at Cas9 Target Sites. Nature Portfolio, 2019.